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Abstract
Background: This study aimed at describing usual anesthetic practices for brain-dead donors (BDD) during an
organ procurement (OP) procedure and to assess the knowledge and self-confidence of French anesthesiologists
with this practice.
Methods: An electronic and anonymous survey with closed-questions about anesthetic management of BDD was
distributed to French anesthesiologists via the mailing list of the French Society of Anesthesiology and Intensive
Care Medicine.
Results: Four hundred fifty-eight responses were analyzed. Respondents were mainly attending physicians with
more than 10 years of clinical experience. 78% of them declared being cognizant of guidelines regarding
management of BDD. Advanced hemodynamic monitoring and endocrine substitution were rarely considered by
respondents (31 and 35% of respondents, respectively). 98% of the respondents used crystalloids for fluid
resuscitation. During the procedure, use of neuromuscular blockers, opioids and sedative agents were considered
by respectively 84, 61 and 27% of the respondents. A very high level of agreement (10 [8–10], on a ten-points
Likert-style scale) was reported concerning the expected impact of intraoperative anesthetic management on the
primary function of grafts.
Conclusions: Declared anesthetic practice appeared in accordance with guidelines concerning organ donor
management in the ICU. Further studies are needed to evaluate the specific impact of intraoperative management
during this procedure and thus the need for specific anesthetic guidelines.
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Background
Brain-dead donors (BDD) currently remain the primary
source of grafts for solid organ transplantation across the
world [1, 2]. In this context, appropriate management of
organ donors from the diagnosis of brain death to the end
of the organ procurement (OP) procedure is of paramount
importance to optimize the function of potential grafts.
Intensive care (ICU) management of BDD is well-codified.
This is an active research field [3] and many guidelines
were published and regularly updated over the last years
[4–7]. Conversely, intraoperative and anesthetic manage-
ment of the donor during the OP procedure is far less codi-
fied [2, 8]. French guidelines mainly specify to follow the
same organ resuscitation strategy initiated in the ICU and
only specify that the use of neuromuscular blocking (NMB)
agents and analgesics are justified [5]. Because of the lack
of specific recommendations on the intraoperative and
anesthetic management of OP procedure, we hypothesize
that the practices are disparate.
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In this context, we performed a French national survey
on intraoperative management of BDD by anesthesiologists.
The aims of the study were i) to describe intraopera-
tive anesthetic practices for BDD during an OP pro-
cedure; and ii) to evaluate the knowledge of French
anesthesiologists on this specific practice.
Methods
Questionnaire
We conducted a French national survey on intraopera-
tive anesthetic management of BDD during the OP pro-
cedure. The questionnaire included 33 closed-questions
and one open-ended question (see the Additional file 1).
The questionnaire was anonymous and subdivided into
seven sections taking into account the domains covered
by the guidelines [4–7]: general and demographic data, per-
operative monitoring, hemodynamic management, meta-
bolic management, respiratory management, anesthetic
drugs employment and personal feeling about the pro-
cedure. Intraoperative use of donor management goals
(DMGs) was also evaluated. For questions on standard
practice, a five-point Likert-style scale was provided
(ranging from never to always); for questions covering
provider’s perception of the OP procedure, a ten-point
Likert-style scale ranging from 1 (certainly not agree) to
10 (absolutely agree) was used. Before broadcasting, the
questionnaire was tested and approved by the anesthe-
siologists of our tertiary teaching hospital (European
Georges Pompidou hospital, AP-HP, Paris, France).
According to the French law, no ethic committee ap-
proval was required for this anonymous survey intended
to health professionals.
Survey processing
The questionnaire was meant to target all French anesthe-
siologists. Expected time to complete the questionnaire
was less than 10min. An electronic form of the survey
was compiled using SurveyMonkey® (https://www.survey-
monkey.com). In early September 2017, French anesthesi-
ologists were invited to answer the survey via an email,
sent through the mailing-list of the French Society of
Anesthesia and Intensive Care (Société Française d’Anesthé-
sie-Réanimation, SFAR). The survey was available on-line
during a 4-month period (until end of December 2017). A
follow-up email was sent 2months after the first e-mail, in
November 2017.
French local organization for organ procurement
In France, OP from BDD is only performed in hospitals
accredited by the French Biomedicine Agency which is
the only state agency that regulates and organizes OP
and transplantation in France. In 2017, 182 medical cen-
ters were accredited in France for OP from BDD. In
each center, a dedicated local team (including specialized
nurses) is involved from the identification of the poten-
tial BDD in the ICU to the admission of the deceased
person in the mortuary room. Local OP teams are not
directly involved in the medical management of the
BDD in the ICU or in the OR which remains under the
purview of the attending physician. National French
guidelines regarding BDD management were updated in
2005 by the French society of anesthesia and intensive
care medicine and the Biomedicine Agency [5]. Autho-
rized centers are incited to develop local procedures
based on guidelines.
Data analysis
Results are reported as count (%) for categorical variables
and median (25th–75th percentiles) for continuous vari-
ables. For questions pertaining to practice, in order to
simplify the interpretation of the results, the answers
“never” and “seldom” were grouped, as well as the answers
“always”, “often” and “regularly”. Reported responses were
compared between more junior respondents (including
residents and doctors with less than 10 years of clinical
experience) and more senior respondents (doctors with
more than 10 years of clinical experience). The Pearson
chi-square test was used to compare categorial variables.
Analyses were performed using Microsoft® Excel software
(2017) and SPSS software version 20 (SPSS, Chicago, IL,
USA). All tests were 2-sided with p < 0.05 considered to
define statistical significance.
Results
Respondent characteristics
Four hundred and fifty-eight anesthesiologists answered
the survey during the study period. General characteris-
tics of the respondents are described in Table 1. Among
the respondents, 359 (78%) declared having knowledge
on ICU BDD management guidelines; less junior respon-
dents claimed being cognizant of these recommenda-
tions than senior respondents: 72% vs. 86% (p < 0.001)
(Additional file 1: Table S1).
Per-operative monitoring
Almost all respondents (98%) declared always using the
standard intraoperative monitoring equipment required by
the SFAR (i.e., electrocardiogram, blood pressure, SpO2 and
end-tidal CO2) during the OP procedure. Detailed answers
concerning other optional monitoring are presented in the
Fig. 1. Invasive blood pressure and invasive temperature
monitoring were reported to be frequent (97 and 89%, re-
spectively). Blood lactate or hemoglobin monitoring during
the procedure is less frequent (50 and 74%, respect-
ively). Most of the respondents (69%) did not report
the use of advanced hemodynamic monitoring in this
context. When an advanced hemodynamic monitoring
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is used, pulse pressure analysis seems to be the most
commonly used device in this setting (63%).
Donor management during organ procurement
DMGs: 358 (78%) respondents reported to use pre-
specified DMGs during the OP procedure, without sig-
nificant difference according to the level of seniority
(Additional file 1: Table S1). This included: targeted
mean arterial pressure range of 60–70mmHg for 305
(67%) respondents and temperature > 35 °C for 96% of
the respondents.
Hemodynamic management (Additional file 1: Figure S1)
presents the distribution of the answers concerning intra-
operative fluid management. Briefly, 95% of the responding
anesthesiologists did not used starches for fluid resus-
citation and 98% of them reported using crystalloids
in this context. The most frequently used crystalloids
were ringer lactate (45%) and 0.9% saline (38%). A
hemoglobin threshold of 7 g.dL− 1 was considered for
transfusion by 298 (65%) respondents whereas 21 (5%)
of them considered that blood transfusion was not
indicated in this setting.
Pulmonary management: most anesthesiologists (93%)
reported implementing a protective ventilation strategy
in the OR and 92% of them declared realizing recruit-
ment maneuvers during the procedure (routinely in 55%
of cases). More junior respondents appeared to imple-
ment more often a protective ventilation than the senior
respondents (Additional file 1: Table S1).
Endocrine substitution: during the OP procedure, hor-
monal resuscitation was not considered by 65% of the
respondents, without significant difference between re-
spondents (Additional file 1: Table S1). When hormonal
replacement therapy was considered, hormone substitu-
tion protocol varied substantially across practitioners
except for triiodothyronine that was not used by 93% of
the respondents (Additional file 1: Figure S2).
Anesthetic management during organ procurement
Responses concerning anesthetic drugs utilization are re-
ported in the Fig. 2. Use of NMB, opioids and sedative
agents was considered by respectively 84, 61 and 27% of
the respondents. Among anesthesiologists who declared
using a sedative agent for the procedure, the most popular
agents were volatile anesthetics (65%). For 76% of the re-
spondents, administration of unfractionned heparin is only
done when asked by surgeons or the OP coordinator.
Provider’s perceptions
Provider’s perception concerning the anesthetic manage-
ment of BDD was evaluated using a numeric scale ranging
from 1 to 10. The presence of an attending anesthesiologist
in the OR during the procedure was deemed necessary
with an agreement of 8 (7–10). The question of feeling
enough prepared for OP procedure was rated with a
score of 6 (5–8). Consistently, responding anesthesiolo-
gists considered that further specific recommendations
on anesthetic management of BDD would be useful
(score of agreement: 9 (8–10)). A very high level of
agreement (10 (8–10)) was also reported concerning
the expected impact of intraoperative anesthetic man-
agement on the primary function of grafts.
Discussion
Our study aimed at describing current practices and
perceptions of a large panel of anesthesiologists on the
intraoperative management of BDD. The few existing
recommendations on the subject are essentially based
on expert opinions or extrapolated from ICU guidelines
for BDD management [1, 2]. Briefly, our survey sug-
gests that anesthetic practices concerning monitoring,
DMGs, fluid resuscitation and ventilatory management
are in agreement with the current ICU guidelines
Table 1 Characteristics of the respondents
Respondents
(n = 458)
Type of institution
University hospital 267 (58%)
Non-university hospital 191 (42%)
Function of the respondent
Resident 48 (10%)
Fellow 53 (12%)
Attending physician 335 (73%)
Professor 22 (5%)
Field of activitya
Full-time anaesthesiology 188 (46%)
Full-time ICU 42 (10%)
Shared activity (both anaesthesiology and ICU) 180 (44%)
Professional experience > 10 yearsa 209 (51%)
Numbers of OP procedures occurred last year per establishment
< 5 procedures 55 (12%)
5–10 procedures 95 (21%)
10–20 procedures 132 (29%)
> 20 procedures 176 (38%)
Numbers of BDD personally managed in the OR by respondent during
last year
None 71 (16%)
1–4 307 (67%)
≥ 5 80 (17%)
Existence of a written protocol for anaesthetic
management of BDD
197 (76%)
Data are expressed as n (%)
aExcluding residents
ICU intensive care unit, BDD brain dead donor, OP organ procurement, OR
operating room
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despite significant difference between the respondents
according to their level of seniority [4–7]. Particularly,
more senior anesthesiologists were more likely to re-
port knowledge of the current ICU guidelines. Con-
versely, more junior doctors appeared more likely to
use a protective ventilation strategy, maybe because
younger anesthesiologists were more trained in the era
of lung-protective ventilation [9].
In the absence of specific anesthetic guidelines, main-
taining the same level of care implemented in ICU is fun-
damental, as raised in a recent review [2]. Recent findings
concerning the use of mild hypothermia (34–35 °C) to
improve renal grafts recovery does not seem to be inte-
grated into current practices [3]. The low reported use of
hormone substitution may be surprising. However, this is
in agreement with the French guidelines which do not
Fig. 2 Declared practices concerning anesthetic drugs utilization during the organ procurement procedure
Fig. 1 Detailed answers concerning the use of complementary monitoring during the organ procurement procedure
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support systematic endocrine substitution (except for
vasopressin analogs in case of diabetes insipidus) [5].
This point differs with north-American guidelines [6, 7].
However, the level of evidence concerning the benefit of
hormonal substitution (such as corticosteroids supple-
mentation) remains relatively limited in this context [10].
The use of an advanced hemodynamic monitoring
during the OP procedure did not seem to be a part of
standard practices for a majority of the respondents in
our survey. To our knowledge, there is no published
data concerning the best device for hemodynamic as-
sessment in this context. If pulse pressure variations
could be use in the setting of brain death to guide
fluid therapy [11], a recent randomized study failed to
demonstrate any benefit (in terms of number of or-
gans transplanted) of using a protocolized fluid ther-
apy based on pulse-pressure variation and cardiac
index [12].
The use of anesthetic drugs during the OP proced-
ure remains a matter of debate [13]. In the context of
brain death, the goal of anesthetic medications is es-
sentially to control any possible hemodynamic and/or
motor response resulting from spinal cord reflexes,
thereby justifying the use of neuromuscular blocking
and analgesic agents during the OP procedure [5].
Opioids alone may be insufficient to control catechol-
amine release induced by surgical stimulation [14].
The use of volatile anesthetic, as “vasodilator agents”, may
thus be justified [2, 8]. In addition, a potential beneficial ef-
fect of volatile anesthetic agents on ischemia-reperfusion
injuries has been suggested and could further justify their
use in this context [2, 4, 8]. However, the level of scientific
evidence remains relatively limited and further investiga-
tions are needed.
Finally, the most interesting finding of our study may
be the high perceived impact of intraoperative manage-
ment on the primary function of the grafts. Consistently
the responders reported having high expectations from
the scientific societies to produce specific guidelines on
anesthetic management for BDD. Further research in the
area is needed to give consistency to future evidence-
based guidelines.
This declarative study carries some limitations. The sur-
vey was sent to an unselected panel of French anesthesiolo-
gists, members of the French Society of Anesthesia and
Intensive Care Medicine. Although this panel is supposed
to be representative of the overall population of prac-
ticing anesthesiologists, we cannot rule out some de-
gree of responder bias and thus the results may not be
fully representative of the actual current practices. Fur-
thermore, our results might not reflect the practices
outside France, especially since there are some known
discrepancies between current national guidelines con-
cerning BDD management [5–7].
Conclusions
Declared anesthetic practices concerning intraoperative
management of BDD during organ procurement proce-
dures are in accordance with national French guidelines
on organ donor management. Further studies are needed
to investigate this specific area of donor management, to
evaluate the potential impact of specific interventions
(such as the use of anesthetic agents, hormone substitu-
tion or meeting intraoperative specific donor manage-
ment goals…) on the graft function after transplantation
and to build future high-quality anesthetic guidelines on
intraoperative management of BDD.
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